WealthCare Investment Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
+2,201
New +$196K 0.06% 189
2024
Q4
Sell
-3,946
Closed -$257K 147
2024
Q3
$257K Sell
3,946
-1,648
-29% -$96.1K 0.11% 116
2024
Q2
$330K Sell
5,594
-393
-7% -$24.6K 0.15% 101
2024
Q1
$477K Sell
5,987
-333
-5% -$25.4K 0.23% 85
2023
Q4
$510K Sell
6,320
-546
-8% -$38.9K 0.28% 78
2023
Q3
$479K Sell
6,866
-746
-10% -$52.9K 0.29% 70
2023
Q2
$530K Buy
7,612
+568
+8% +$40.4K 0.32% 65
2023
Q1
$523K Sell
7,044
-783
-10% -$65.7K 0.32% 67
2022
Q4
$729K Buy
7,827
+3,262
+71% +$315K 0.5% 49
2022
Q3
$435K Buy
4,565
+666
+17% +$65.9K 0.36% 67
2022
Q2
$361K Buy
3,899
+20
+0.5% +$1.95K 0.31% 73
2022
Q1
$407K Sell
3,879
-8
-0.2% -$840 0.36% 65
2021
Q4
$401K Buy
+3,887
New +$359K 0.39% 62

Other funds holding CVS

WealthCare Investment Partners's CVS Position: Q2 2026 in Review

WealthCare Investment Partners opened a new position in CVS Health (CVS) in Q2 2026: 2,201 shares worth $228K. The stake represents 0.06% of the portfolio and ranks #189 among its holdings. This is a return to the name: WealthCare Investment Partners previously reported a position in CVS as recently as Q3 2024.

WealthCare Investment Partners first reported a position in CVS in Q4 2021 and has held it in 13 quarters since. The position peaked at $729K in Q4 2022. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • WealthCare Investment Partners held 2,201 shares of CVS Health worth $228K as of Q2 2026.
  • CVS Health was a new WealthCare Investment Partners position in Q2 2026.
  • CVS Health made up 0.06% of WealthCare Investment Partners's portfolio in Q2 2026, its #189 holding.
  • WealthCare Investment Partners first reported a position in CVS Health in Q4 2021 and has held it in 13 quarters since.
  • WealthCare Investment Partners's CVS Health position peaked at $729K in Q4 2022.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on WealthCare Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.